Video

What COVID-19 Vaccines Teach Us About All Tech Transfers

Source: Outsourced Pharma

Are there “lessons learned” and “best practices” from the COVID-19 vaccine efforts you can apply to tech transfers of your own projects – be they small molecule, biologics, or cell and gene therapies?

View the On-Demand version of OP-Virtual from our discussion on November 4, 2020 on what we’ve learned thus far, and how to “transfer” that knowledge to your projects.

Our panelists:

  • Bikash Chatterjee, CEO | Pharmatech Associates
  • David A. Dodd, Chairman, CEO | GeoVax
  • Marcelo Omelczuk, (former) VP, Global Pharmaceutical Technology and Launch Management | Allergan
  • Mark F. Witcher, Ph.D., (former) VP Manufacturing | Amgen & (former) SVP Operations | Covance
  • Louis Garguilo, Chief Editor | Outsourced Pharma

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: